Horizon Pharma is a specialty and generic drug manufacturing company. The company is focused on the identification, development, acquisition, and commercialization of differentiated and accessible medicines that address unmet medical needs. The overwhelming majority of revenue is generated in the United States. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
| Website: | www.horizonpharma.com |
| Email: | investor-relations@horizonpharma.com |
| Main Phone: | +353 17722100 |
| Address: | 1 Burlington Road |
| Address 2: | Connaught House, 1st Floor |
| City / Town: | Dublin 4 |
| Country: | IRL |
| Postal Code: | D04 C5Y6 |
| Exchange: | NGS |
| CEO: | Timothy P. Walbert |
| Employees: | 990 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 19.76 | Change $ -0.24 | Change % -1.20 | Tick N/A |
| Bid 19.69 | Bid Size 100.00 | Ask 20.64 | Ask Size 600.00 |
| Open 20.02 | High 20.61 | Low 19.64 | Prev Close 20.00 |
| Last Trade | Volume 2.8 mi | 52 Wk Hi 23.38 | 52 Wk Low 12.55 |
| Market Cap 3.3 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 167,625,915.00 | EPS (TTM) -1.29 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 36 | 64 |
| Number of Buys | 18 | 32 |
| Number of Sells | 18 | 32 |
| Net Activity | 242822 | 343770 |
| Last 10 Buys | Shares |
|---|---|
| Michael G. Grey | 1,000 |
| H. Thomas Watkins | 1,000 |
| H. Thomas Watkins | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Jeffrey W. Bird | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Brian K. Beeler | 1,000 |
| Brian K. Beeler | 1,000 |
| Timothy P. Walbert | 1,000 |
| Brian K. Beeler | 1,000 |
| Robert F. Carey | 1,000 |
| Robert F. Carey | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Virinder Nohria | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Jeffrey W. Sherman | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 24 | 24 | 24 | 24 |
| Low Target Price Estimate | 16 | 16 | 16 | 16 |
| Mean Target Price Estimate | 20 | 20 | 20 | 20 |
| Standard Deviation | 3.21 | 3.21 | 3.21 | 3.21 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-12 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| CT ORDER | 1 | 2018-05-14 | |
| S-8 | Securities offered to employees under employee benefit plans | 10 | 2018-05-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 112 | 2018-05-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 20 | 2018-05-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1.29 | 1.29 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
